Mouse MRP8 and MRP14, two intracellular calcium-binding proteins associated with the development of the myeloid lineage.Lagasse E., Weissman I.L.Blood 79:1907-1915(1992)
Molecular analysis of the mouse S100A9 gene and evidence that the myeloid specific transcription factor C/EBPepsilon is not required for the regulation of the S100A9/A8 gene expression in neutrophils.Nacken W.K.F., Lekstrom-Himes J.A., Sorg C., Manitz M.3.0.CO;2-K>J. Cell. Biochem. 80:606-616(2001)
Isolation of the murine S100 protein MRP14 (14 kDa migration-inhibitory-factor-related protein)
from activated spleen cells
characterization of post-translational modifications and zinc binding.Raftery M.J., Harrison C.A., Alewood P.F., Jones A., Geczy C.L.Biochem. J. 316:285-293(1996)
Loss of S100A9 (MRP14)
results in reduced interleukin-8-induced CD11b surface expression, a polarized microfilament system, and diminished responsiveness to chemoattractants in vitro.Manitz M.-P., Horst B., Seeliger S., Strey A., Skryabin B.V., Gunzer M., Frings W., Schoenlau F., Roth J., Sorg C., Nacken W.Mol. Cell. Biol. 23:1034-1043(2003)
MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes.Vogl T., Ludwig S., Goebeler M., Strey A., Thorey I.S., Reichelt R., Foell D., Gerke V., Manitz M.P., Nacken W., Werner S., Sorg C., Roth J.Blood 104:4260-4268(2004)
Comprehensive identification of phosphorylation sites in postsynaptic density preparations.Trinidad J.C., Specht C.G., Thalhammer A., Schoepfer R., Burlingame A.L.Mol. Cell. Proteomics 5:914-922(2006)
Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock.Vogl T., Tenbrock K., Ludwig S., Leukert N., Ehrhardt C., van Zoelen M.A.D., Nacken W., Foell D., van der Poll T., Sorg C., Roth J.Nat. Med. 13:1042-1049(2007)
S100A8 and S100A9 mediate endotoxin-induced cardiomyocyte dysfunction via the receptor for advanced glycation end products.Boyd J.H., Kan B., Roberts H., Wang Y., Walley K.R.Circ. Res. 102:1239-1246(2008)
Anti-infective protective properties of S100 calgranulins.Hsu K., Champaiboon C., Guenther B.D., Sorenson B.S., Khammanivong A., Ross K.F., Geczy C.L., Herzberg M.C.Antiinflamm. Antiallergy Agents Med. Chem. 8:290-305(2009)
Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides.Bjoerk P., Bjoerk A., Vogl T., Stenstroem M., Liberg D., Olsson A., Roth J., Ivars F., Leanderson T.PLoS Biol. 7:E97-E97(2009)
Inflammation-associated S100 proteins
new mechanisms that regulate function.Goyette J., Geczy C.L.Amino Acids 41:821-842(2011)
S100A9 differentially modifies phenotypic states of neutrophils, macrophages, and dendritic cells
implications for atherosclerosis and adipose tissue inflammation.Averill M.M., Barnhart S., Becker L., Li X., Heinecke J.W., Leboeuf R.C., Hamerman J.A., Sorg C., Kerkhoff C., Bornfeldt K.E.Circulation 123:1216-1226(2011)
Induction of nuclear factor-kappaB responses by the S100A9 protein is Toll-like receptor-4-dependent.Riva M., Kaellberg E., Bjoerk P., Hancz D., Vogl T., Roth J., Ivars F., Leanderson T.Immunology 137:172-182(2012)